Consultation Hub

Public consultation on the Delegate’s interim decision on nicotine scheduling was held between 23 September and 12 November. The interim decision and public consultation relate to a delegate-initiated proposal referred to the June 2020 meeting of the Advisory Committee on Medicines and Chemicals Scheduling in joint session (Joint ACMS-ACCS #25).

We received 2385 submissions in response to the public consultation, including seven submissions that were received offline. Respondents provided feedback on the proposed changes to the Poisons Standard. We appreciate all of the feedback that we received.

The Delegate considered all submissions prior to making the final decision on nicotine scheduling. The final decision was published on 21 December 2020 on the TGA website.

We asked for your feedback on the new ARPANSA Standard for Limiting Exposure to Radiofrequency Fields – 100 KHz to 300 GHz (RPS S-1) because we want to make sure that the standard is fit for purpose and provides clear guidance to industries and regulators to ensure the safety of Australian workers and the general public including people of all ages and health status.

We received 61 submissions from a range of stakeholders, including health authorities, scientists, academic bodies and members of the general public. There were a range of technical comments, questions, and suggestions, as well as comments from members of the public expressing concern about the certainty of the science underpinning the exposure limits.

We have reviewed all submissions and made some amendments, primarily to clarify technical aspects of the Standard. The revised Standard and our responses to individual consultation comments will now undergo formal approvals prior to publication.  

The new Standard will be published on the ARPANSA website in the first quarter of 2021.

Public consultation on the Delegate’s interim decisions, in relation to scheduling proposals referred to the June 2020 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS), was held between 9 September 2020 and 13 October 2020.

We received 41 submissions in response to the consultation. Respondents provided feedback on the proposed changes to the Poisons Standard. We appreciate all of the feedback we received.

The Delegate considered all submissions in making the final decision on these proposals.

Final decisions regarding oxymetazoline, eletriptan, clotrimazole, sildenafil, ibuprofen and cumyl-pegaclone were published on 25 November 2020.

The final decision for cannabidiol (private application and delegate initiated) was published on 15 December 2020.